Literature DB >> 18190336

Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.

Stefano Bonora, Andrea Calcagno, Silvia Fontana, Antonio D'Avolio, Marco Siccardi, Federico Gobbi, Giovanni Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18190336     DOI： 10.1086/523722

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

Authors:  G L Birbeck; J A French; E Perucca; D M Simpson; H Fraimow; J M George; J F Okulicz; D B Clifford; H Hachad; R H Levy
Journal:  Neurology       Date:  2012-01-04       Impact factor: 9.910

Review 2.  Tipranavir: a review of its use in the management of HIV infection.

Authors:  Jennifer S Orman; Caroline M Perry
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.